Showing results (621-630 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|April 14, 2020
In Defense of Secondary Pharmaceutical Patents in Drug Discovery and DevelopmentIsrael Agranat, Hili Marom
ACS Medicinal Chemistry Letters|March 16, 2023
Correction to "Using Imidazo[2,1-b][1,3,4]thiadiazol Skeleton to Design and Synthesize Novel MNK Inhibitors"Xin Jin, Tingting Qiu, Jianling Xie, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Continuous-Flow Technology for Chemical Rearrangements: A Powerful Tool to Generate Pharmaceutically Relevant CompoundsAntonella Ilenia Alfano, Sveva Pelliccia, Giacomo Rossino, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Contemporary Progress and Opportunities in RNA-Targeted Drug DiscoveryAmanda L Garner
ACS Medicinal Chemistry Letters|March 16, 2023
APOBEC3A Catalytic Inactivity Mutation Induces Tertiary Structure DestabilizationKatherine F M Jones, Mohamed Shehata, Michael A Carpenter, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Controlling Ibrutinib's Conformations about Its Heterobiaryl Axis to Increase BTK SelectivitySean T Toenjes, Bahar S Heydari, Samuel T Albright, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Passive Membrane Permeability of Sizable Acyclic β-Hairpin PeptidesJillene Moxam, Sarah Naylon, Alexis D Richaud, et al.
ACS Medicinal Chemistry Letters|March 16, 2023
Trust Your Gut: Strategies and Tactics for Intestinally Restricted DrugsRuth Dorel, Alice R Wong, James J Crawford
ACS Medicinal Chemistry Letters|April 21, 2015
Peptidic inhibitors for in vitro pentamer formation of human papillomavirus capsid protein l1Ding-Yi Fu, Shi Jin, Dong-Dong Zheng, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial estersElina Puljula, Petri Turhanen, Jouko Vepsäläinen, et al.
Pageof 438